C163H202FN23O6 — CID 159152236
4-[3-[4-[3-[[cyclopentylmethyl(ethyl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[cyclopropyl-(1-methylpiperidin-4-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[ethyl-[[(3S)-piperidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[ethyl(pyrrolidin-3-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[ethyl-[[(3S)-pyrrolidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[2-fluoro-5-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol (PubChem CID 159152236) has the molecular formula C163H202FN23O6 and a molecular weight of 2598.56 g/mol. Its IUPAC name is 4-[3-[4-[3-[[cyclopentylmethyl(ethyl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[cyclopropyl-(1-methylpiperidin-4-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[ethyl-[[(3S)-piperidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[ethyl(pyrrolidin-3-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[ethyl-[[(3S)-pyrrolidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[2-fluoro-5-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol.
| Compound Name | 4-[3-[4-[3-[[cyclopentylmethyl(ethyl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[cyclopropyl-(1-methylpiperidin-4-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[ethyl-[[(3S)-piperidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[ethyl(pyrrolidin-3-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[ethyl-[[(3S)-pyrrolidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[2-fluoro-5-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol |
|---|---|
| PubChem CID | 159152236 |
| Molecular Formula | C163H202FN23O6 |
| Molecular Weight | 2598.56 g/mol |
| Exact Mass | 2596.62 |
| IUPAC Name | 4-[3-[4-[3-[[cyclopentylmethyl(ethyl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[cyclopropyl-(1-methylpiperidin-4-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[ethyl-[[(3S)-piperidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[ethyl(pyrrolidin-3-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[ethyl-[[(3S)-pyrrolidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[2-fluoro-5-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol |
| SMILES | CCN(Cc1cccc(-c2ccnc(CCCc3ccc(O)cc3)n2)c1)C1CCNC1.CCN(Cc1cccc(-c2ccnc(CCCc3ccc(O)cc3)n2)c1)CC1CCCC1.CCN(Cc1cccc(-c2ccnc(CCCc3ccc(O)cc3)n2)c1)C[C@H]1CCNC1.CCN(Cc1cccc(-c2ccnc(CCCc3cccc(O)c3)n2)c1)C[C@H]1CCCNC1.CN1CCC(N(Cc2cccc(-c3ccnc(CCCc4ccc(O)cc4)n3)c2)C2CC2)CC1.C[C@H]1CNCCN1Cc1ccc(F)c(-c2ccnc(CCCc3cccc(O)c3)n2)c1 |
| InChI | InChI=1S/C29H36N4O.C28H36N4O.C28H35N3O.C27H34N4O.C26H32N4O.C25H29FN4O/c1-32-18-15-26(16-19-32)33(25-10-11-25)21-23-5-2-6-24(20-23)28-14-17-30-29(31-28)7-3-4-22-8-12-27(34)13-9-22;1-2-32(21-24-10-6-15-29-19-24)20-23-9-3-11-25(17-23)27-14-16-30-28(31-27)13-5-8-22-7-4-12-26(33)18-22;1-2-31(20-23-7-3-4-8-23)21-24-10-5-11-25(19-24)27-17-18-29-28(30-27)12-6-9-22-13-15-26(32)16-14-22;1-2-31(20-23-13-15-28-18-23)19-22-6-3-7-24(17-22)26-14-16-29-27(30-26)8-4-5-21-9-11-25(32)12-10-21;1-2-30(23-13-15-27-18-23)19-21-6-3-7-22(17-21)25-14-16-28-26(29-25)8-4-5-20-9-11-24(31)12-10-20;1-18-16-27-12-13-30(18)17-20-8-9-23(26)22(15-20)24-10-11-28-25(29-24)7-3-5-19-4-2-6-21(31)14-19/h2,5-6,8-9,12-14,17,20,25-26,34H,3-4,7,10-11,15-16,18-19,21H2,1H3;3-4,7,9,11-12,14,16-18,24,29,33H,2,5-6,8,10,13,15,19-21H2,1H3;5,10-11,13-19,23,32H,2-4,6-9,12,20-21H2,1H3;3,6-7,9-12,14,16-17,23,28,32H,2,4-5,8,13,15,18-20H2,1H3;3,6-7,9-12,14,16-17,23,27,31H,2,4-5,8,13,15,18-19H2,1H3;2,4,6,8-11,14-15,18,27,31H,3,5,7,12-13,16-17H2,1H3/t;24-;;23-;;18-/m.0.0.0/s1 |
| InChIKey | KJLFXGBACJKAAT-MZTMTRPSSA-N |
| XLogP | 28.59 |
| TPSA | 346.86 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 55 |
| Heavy Atoms | 193 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2598.56 |
| LogP ≤ 5 | 28.59 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 29 |